AtriCure hits snag with US approval of ablation tech for AF; panel vote due tomorrow
This article was originally published in Clinica
Executive Summary
US approval of AtriCure's Synergy ablation system for the treatment of atrial fibrillation (AF) has been thrown into doubt after the FDA questioned the safety and efficacy of the technology in its target patient population.